Evidence map›Paper›PMID 36116918›Full record

ArticleJournal of microbiology and biotechnology2022

Novel Antibacterial, Cytotoxic and Catalytic Activities of Silver Nanoparticles Synthesized from Acidophilic Actinobacterial SL19 with Evidence for Protein as Coating Biomolecule.

Magdalena Wypij, Maciej Ostrowski, Kamil Piska, Katarzyna Wójcik-Pszczoła, Elżbieta Pękala, Mahendra Rai, Patrycja Golińska

Open access · bronzeAbstract read
In one paragraph

Article in Journal of microbiology and biotechnology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.2field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 18 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Pullulan-based films impregnated with silver nanoparticles from theFrontiers in bioengineering and biotechnology · 2023
    Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 2 countries.

Magdalena WypijDepartment of Microbiology, Nicolaus Copernicus University, Torun 87-100, Poland.
Maciej OstrowskiDepartment of Biochemistry, Nicolaus Copernicus University, Torun 87-100, Poland.
Kamil PiskaDepartment of Pharmaceutical Biochemistry, Faculty of Pharmacy, Jagiellonian University Medical College, Medyczna 9, 30-688, Kraków, Poland.
Katarzyna Wójcik-PszczołaDepartment of Pharmaceutical Biochemistry, Faculty of Pharmacy, Jagiellonian University Medical College, Medyczna 9, 30-688, Kraków, Poland.
Elżbieta PękalaDepartment of Pharmaceutical Biochemistry, Faculty of Pharmacy, Jagiellonian University Medical College, Medyczna 9, 30-688, Kraków, Poland.
Mahendra RaiDepartment of Microbiology, Nicolaus Copernicus University, Torun 87-100, Poland.
Patrycja GolińskaDepartment of Microbiology, Nicolaus Copernicus University, Torun 87-100, Poland.
Nicolaus Copernicus University · PLJagiellonian University · PL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Silver nanoparticles (AgNPs) have potential applications in medicine, photocatalysis, agriculture, and cosmetic fields due to their unique physicochemical properties and strong antimicrobial activity. Here, AgNPs were synthesized using actinobacterial SL19 strain, isolated from acidic forest soil in Poland, and confirmed by UV-vis and FTIR spectroscopy, TEM, and zeta potential analysis. The AgNPs were polydispersed, stable, spherical, and small, with an average size of 23 nm. The FTIR study revealed the presence of bonds characteristic of proteins that cover nanoparticles. These proteins were then studied by using liquid chromatography with tandem mass spectrometry (LC-MS/ MS) and identified with the highest similarity to hypothetical protein and porin with molecular masses equal to 41 and 38 kDa, respectively. Our AgNPs exhibited remarkable antibacterial activity against

Indexed as

Anti-Infective AgentsAntineoplastic AgentsMetal NanoparticlesAmpicillinAnti-Bacterial AgentsEscherichia coliHumansKanamycinMicrobial Sensitivity TestsPorinsSilverSoilStreptomycinTetracyclinesAmpicillinAnti-Bacterial AgentsAnti-Infective AgentsAntineoplastic AgentsKanamycinPorinsSilverSoilStreptomycinTetracyclinesAcidophilic actinomycetesantibacterial and anticancer activitycapping agentcatalytic activitygreen synthesisnanosilver

Identifiers

PMID36116918
PMCPMC9628977
OpenAlexW4296330805

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.